Peptide profile
BPC-157
Systemic healing for wounds, tendons, and gut · also known as Body Protection Compound-157, PL 14736
Compare BPC-157 with other peptides →Summary
A synthetic pentadecapeptide derived from a protein in gastric juice, studied for tissue repair, gut protection, and musculoskeletal healing.
- Typical dose
- 250-500 mcg/day
- Half-life
- ~4 hours
- Route
- Subcutaneous, Intramuscular
- Cycle length
- 4-6 weeks
Mechanism
How it works
Thought to upregulate growth factor receptors (VEGFR2, EGF), promote angiogenesis, and modulate the nitric oxide system to accelerate healing.
Reported in research
Benefits
- Tendon and ligament repair
- Gut lining protection and ulcer healing
- Reduced systemic inflammation
- Bone and joint recovery
Context, not a prescription
Dosing
- Typical range
- 250-500 mcg/day (Subcutaneous, Intramuscular)
- Cycle length
- 4-6 weeks
- Half-life
- ~4 hours
Safety
Side effects & contraindications
Possible side effects
- Injection-site irritation or bruising
- Mild nausea (rare)
Contraindications
- Active malignancy (theoretical concern due to angiogenesis promotion)
- Pregnancy or breastfeeding (insufficient data)
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Less pain, easier movement, and faster healing.
How it works
BPC-157 is like a building boss at a hurt spot. It tells new blood pipes to grow and tells repair cells to make more cells.
It grabs onto special spots on cells. Then it helps cells move to the hurt areas to fix them.
What to expect
You may feel the first effects in 3-7 days. Full help comes by 4-6 weeks.
- Days 3-7: Less pain and swelling.
- Weeks 2-3: Cuts close up better.
- Weeks 4-6: Lots of healing happens.
Good to know
- Start with a smaller amount (200mcg)
- Switch the spot you use each time
- Keep everything clean and germ-free
Staying safe
- Sore spot where you got the shot
- Small headache
- Feeling tired for a little while
Avoid if you have:
- People who have cancer right now
- Women who are pregnant or breastfeeding
- People taking blood-thinning medicine
Mechanism of action
BPC-157 stimulates angiogenesis, modulates nitric oxide pathways, and influences gene expression related to repair processes.
Binds to growth factor receptors and promotes cell migration to damaged tissues.
Pharmacodynamics
Initial effects within 3-7 days, full benefits by 4-6 weeks.
Reduced pain, improved mobility, accelerated tissue healing.
Timeline
- Days 3-7: Reduced pain and inflammation.
- Weeks 2-3: Improved wound closure.
- Weeks 4-6: Significant tissue repair.
Comparisons
- BPC-157 — effectiveness High, safety Good, cost $$, Medium to use
- TB-500 — effectiveness Moderate, safety Good, cost $$, Medium to use
Adverse effects
Common:
- Injection site pain
- Mild headache
- Temporary fatigue
Rare:
- Dizziness
- Nausea
- Irritability
Contraindications & risk mitigation
Contraindicated in:
- Individuals with active cancer
- Pregnancy or breastfeeding
- Those on blood thinners
- Start with lower dose (200mcg)
- Rotate injection sites
- Use sterile technique
Qué hace
Menos dolor, movimiento más fácil y cicatrización más rápida.
Cómo funciona
BPC-157 es como un jefe de obra en una zona lesionada. Le dice a los nuevos vasos sanguíneos que crezcan y a las células reparadoras que se multipliquen.
Se une a puntos específicos en las células. Luego ayuda a que las células se desplacen hacia las zonas dañadas para repararlas.
Qué esperar
Puedes notar los primeros efectos en 3-7 días. El beneficio completo llega en 4-6 semanas.
- Días 3-7: Menos dolor e hinchazón.
- Semanas 2-3: Las heridas cierran mejor.
- Semanas 4-6: Se produce una gran reparación tisular.
Bueno saber
- Comenzar con una dosis menor (200 mcg)
- Cambiar el lugar de la inyección cada vez
- Mantener todo limpio y libre de gérmenes
Manteniéndose seguro
- Dolor en el lugar de la inyección
- Dolor de cabeza leve
- Cansancio por un tiempo
Evitar si tienes:
- Personas con cáncer activo
- Mujeres embarazadas o en lactancia
- Personas que toman medicamentos para diluir la sangre
Mecanismo de acción
BPC-157 estimula la angiogénesis, modula las vías del óxido nítrico e influye en la expresión génica relacionada con los procesos de reparación.
Se une a los receptores de factores de crecimiento y promueve la migración celular hacia los tejidos dañados.
Farmacodinamia
Efectos iniciales en 3-7 días, beneficios completos en 4-6 semanas.
Reducción del dolor, mejora de la movilidad y cicatrización tisular acelerada.
Cronología
- Días 3-7: Reducción del dolor y la inflamación.
- Semanas 2-3: Mejora en el cierre de heridas.
- Semanas 4-6: Reparación tisular significativa.
Comparaciones
- BPC-157 — efectividad Alta, seguridad Buena, costo $$, Media de usar
- TB-500 — efectividad Moderada, seguridad Buena, costo $$, Media de usar
Efectos adversos
Comunes:
- Dolor en el sitio de inyección
- Cefalea leve
- Fatiga temporal
Raros:
- Mareos
- Náuseas
- Irritabilidad
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Individuos con cáncer activo
- Embarazo o lactancia
- Personas que toman anticoagulantes
- Comenzar con dosis menor (200 mcg)
- Rotar los sitios de inyección
- Usar técnica estéril
Reference data
Specifications
- Molecular formula
- C62H98N16O22
- Molecular weight
- 1419.5 g/mol
- Half-life
- ~4 hours
- Route
- Subcutaneous, Intramuscular
- Cycle length
- 4-6 weeks
- Storage
- Lyophilized: room temperature short-term. Reconstituted: refrigerate at 2-8 C, use within 30 days.
- Legal status
- Research chemical; not FDA-approved for human use.
FAQ
Common questions
Is BPC-157 FDA-approved?
No, it is not FDA-approved and is sold for research purposes only.
Can BPC-157 be applied topically to wounds?
Yes, topical BPC-157 is used for skin wounds and ulcers in research settings.
What is the evidence level?
This compound is classified as Animal data. Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Research
Research & sources
Current evidence for BPC-157 is rated as Animal data. Research is based primarily on animal models.
- 1. Stable gastric pentadecapeptide BPC-157 (2020) — DOI:10.3390/ph13090268
- 2. BPC-157 and wound healing (2010) — DOI:10.1111/j.1749-6632.2009.05124.x
- 3. Sikiric et al. — BPC-157 review on tissue repair
- 4. Chang et al. — BPC-157 and tendon healing
Explore